Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner

Journal of Neuroscience Research

Volumn 62, Issue 4, 2000, Pages 503-509

  Barger, Steven W ^a,b,c   Chavis, Janet A ^b   Drew, Paul D ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PRASTERONE; STERYL SULFATASE;

AGE; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; GENETIC TRANSCRIPTION; HORMONE INHIBITION; INFLAMMATION; MICROGLIA; MONONUCLEAR PHAGOCYTE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ENCEPHALITIS; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 0034670008     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20001115)62:4<503::AID-JNR4>3.0.CO;2-A     Document Type: Article

References (47)

1. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
2. Induction of nueroprotective κB-dependent transcription by secreted form of the Alzheimer β-amyloid precursor
3. Changes in serum concentrations of conjugated and unconjugated steroids in 40-80-year-old men
4. Relationship of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study
5. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
6. Reactive nitrogen intermediates in human neuropathology: An overview
7. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease
8. Delayed onset of Alzheimer disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
9. Cholesterol oxides induce prorammed cell death in microglial cells
10. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
11. Species differences in the generation of reactive oxygen species by microgila
12. Inducible nitric oxide synthase activity in cloned murine microglial cells
13. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation
14. Activation of human monocytes by LPS and DHEA
15. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
16. DHEAS inhibits TNF production in monocytes, astrocytes, and microglial cells
17. Regulation of MHC class I and β2-microglobulin gene expression in human neuronal cells: Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes
18. Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases
19. Interleukin-1 expression in different plaque types in Alzheimer disease: Significance in plaque evolution
20. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
21. Inhibitors of the proteosome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB
22. Transcription factor NF-κB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease
23. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity
24. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB
25. DHEA and DHEA-S: A review
26. A redox-based mechanism for the neuro-protective and neurodestructive effects of nitric oxide and related nitroso-compounds
27. Nitric oxide and macrophage function
28. Neuroprotection by dehydroepiandrosterone-sulfate: Role of an NF-κB-like factor
29. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity
30. Activation of microglial cells by β-amyloid protein and interferon-gamma
31. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
32. Inhibition of macrophage generation of dehydroepiandrosterone
33. Glial cytokines in Alzheimer disease: Review and pathogenic implications
34. Macrophage colony-stimulating factor augments β-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells
35. Serum dehydroepiandrosterone sulfate in Alzheimer disease and in multi-infarct dementia
36. Eudocrine regulation of murine macrophage function: Effects of dehydroepiandrosterone, androstenediol, and androstenetriol
37. High mobility group-I(Y) protein facilitates nuclear factor-κB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer
38. Peroxisome proliferator-activated receptor α required for gene induction by dehydroepiandrosterone-3 β-sulfate
39. Clinical trial of indomethacin in Alzheimer disease
40. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes
41. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
42. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macfophages in vitro in asbestosis
43. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type
44. No NO prevents parkinsonism
45. Serum dehydroepiandrosterone sulfate levels as an individual marker
46. Roles of CNS macrophages in neurodegeneration